Discovery advances fight against phleboviruses

November 7, 2012
Phlebovirus: The RNA genome is in yellow and each of the "N" protein molecules (N = nucleocapsid protein) is in a contrasting color.

(Medical Xpress)—Researchers in the Life Sciences Institute at the University of Michigan have discovered how a particular type of virus hides and protects its genetic information from the immune system, a design that allows it to replicate inside cells of an infected person or animal.

The discovery, detailed Nov. 5 in the , offers the first picture of a potential for phleboviruses, a family of viruses that attacks humans and animals via insect bites.

An increasing number of human cases of different types of phleboviruses have been diagnosed in the last five years, and some have been fatal. There are currently no or immunizations for phleboviruses.

The phleboviruses are part of the bunyavirus family, negative-sense RNA viruses that include about 330 types. Negative-sense viruses have a single strand of RNA, which they must replicate upon entering the cell. Other negative-sense RNA viruses include those that cause flu, rabies and measles.

Researchers in the lab of Janet Smith, a faculty member at the Life Sciences Institute, professor of biological chemistry and the director of the Center for , isolated a protein from the Rift Valley Fever virus, a phlebovirus that typically infects cattle but has also caused fatal outbreaks among in Egypt, Kenya, Saudi Arabia and Yemen.

They found that the Rift Valley Fever virus hides its genome within a that is "very weird," Smith says. They used X-ray crystallography to diagram the structure of the and found that it tucks the in a narrow groove in the protein, concealing the RNA inside. Unlike other viruses—like flu or measles—that package their RNA genomes in regular, symmetrical protein shapes, the Rift Valley Fever virus threads its RNA into a seemingly random string of proteins.

Working with Georgios Skiniotis, a faculty member at the Life Sciences Institute and assistant professor of , the researchers used electron microscopy to show that the entire virus uses the same RNA-hiding scheme as the isolated protein.

"We describe it as nature's most 'primitive' packaging scheme," Smith said.

The body's immune system is always on the lookout for odd RNA strands, Smith says, and by keeping its RNA packed into this little slot in the protein, the virus can escape detection.
Aiming a drug molecule at that slot might interrupt the virus's replication mechanism—and stop its spread.

"It's our first picture of a phlebovirus protein in action, the first step in finding a druggable target," Smith said. "X-ray crystallography and electron microscopy techniques capture pictures of the viral proteins in action, pictures that are essential for developing antiviral drugs and vaccines."

Veterinarians first reported in cattle in Kenya in the early 1900s. More recently, however, other phleboviruses have been discovered.

In 2009, two Missouri farmers became ill with undiagnosed flu-like symptoms of fever, gastrointestinal distress and low platelet count after being bitten by ticks. Scientists determined that they had been infected with a previously unknown phlebovirus that they dubbed the Heartland virus in a paper published in the New England Journal of Medicine in August 2012.

In 2006, farmers in China began to contract an illness with very similar symptoms; in 2009, researchers pinpointed a new phlebovirus, called SFTS virus (for "severe fever with thrombocytopenia syndrome"), and began tracking patients. Since then, about 170 cases have been diagnosed, with a fatality rate of 12-30 percent.

"This is a little-known part of virology," Smith said. "We really don't know many molecular details about the phleboviruses."

Scientists currently assume that the structure of the virus is very similar to other phleboviruses. Smith says the understanding of how this particular phlebovirus hides its RNA also applies to other viruses in the family.

While the number of reported cases of phleboviruses is rising, Smith says the number is probably rising because scientists are able to isolate and observe viruses and to sequence their genomes.

Explore further: Scientists reveal how deadly Marburg virus silences immune system

More information: Phleboviruses encapsidate their genomes by sequestering RNA bases. www.pnas.org/content/early/2012/10/31/1213553109.abstract

Related Stories

New genetically engineered vaccines target Rift Valley fever

August 24, 2011

(PhysOrg.com) -- Researchers from the University of California, Davis, and elsewhere are reporting the development of two genetically engineered vaccines to combat the mosquito-borne Rift Valley fever, devastating to livestock ...

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.